'Neuroscience startup, NeuroTracker, has a virtual training tool with a proven ability to help improve “cognitive fitness.” Jean Castonguay, co-founder, board member and Head of Global Strategic Partnerships at NeuroTracker, explains the science and clinical validation behind their tech and drops some big name users in the process — Manchester United, German and French soccer teams, US special forces, as well as some of the world’s leading sports concussion rehabilitation clinics. What sets the startup apart from other companies in the mental performance space? How have they shored up their science in the face of Lumosity’s Federal Trade Commission suit against false claims about brain health outcomes? It shook up the industry, and NeuroTracker actually feels it strengthened their business and their value proposition. Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019. *** Jessica DaMassa, the emerging ‘It girl’ of health tech interviewing, chats it up with the ‘who’s who’ of the health innovation set on WTF Health. Catch 100s of interviews with leading health tech startups and digital health innovators and the VC investors, accelerators, health insurance companies, pharmas, and hospital systems helping bring their new ideas into the healthcare ‘establishment.’ From AI, Big Data, and blockchain to AR/VR, digital therapeutics, payment model innovation, health policy, and investing, Jessica helps you spot the trends and figure out what’s next…or, ‘What’s The Future?’ Health. (Yes. That’s really what the acronym means.
Tags: healthcare , Big Pharma , health tech , Healthcare innovation , Health IT , digital health , health innovation , WTF Health , Jessica DaMassa , digital therapeutics , health tech startups , dtx , Jean Castonguay , NeuroTracker , Bayer G4A , G4A , G4A Signing Day , Dtx startups , Digital therapeutics startups , Digital health startups , Health tech accelerator , healthtech news , health startups
See also:
comments